Efficacy and safety of ultra rapid iron polymaltose infusion during general anaesthesia

R. M. Browning, N. Alakeson, E. J. O'Loughlin

    Research output: Contribution to journalArticle

    Abstract

    To assess the efficacy and safety of ultra rapid (15 minute) infusion of iron polymaltose to iron deficient patients during general anaesthesia, we performed a prospective, interventional non-randomised study on 99 adult patients with iron deficiency with or without anaemia presenting for surgery under general anaesthesia. Over 15 minutes during the maintenance phase of anaesthesia, patients were given iron polymaltose, 500 mg if not anaemic, or 1,000 mg if anaemic. Haemodynamic stability, immediate or delayed iron-related side-effects and efficacy at six weeks were assessed. The incidence of significant hypotension or the requirement for vasopressor was not different before, during or after the iron infusion. There were no serious intraoperative events (allergic reactions or skin staining). Mean (standard deviation, SD) haemoglobin rose from 121 (14) g/l preoperatively to 131 (12) g/l at six weeks (P <0.001). Mean (SD) ferritin rose from 17 (12) μg/l to 110 (83) μg/l by six weeks (P <0.001). At six weeks only four out of 64 contactable patients (6.25%) had a ferritin of <30 μg/l. The incidence of immediate or delayed side-effects was similar to patients undergoing outpatient iron polymaltose infusions and reflective of a post-surgical population. We conclude that up to 1,000 mg of iron polymaltose can be given over 15 minutes without significant haemodynamic compromise to selected patients undergoing general anaesthesia. Iron polymaltose administered in this way appears efficacious in treating iron deficiency.

    Original languageEnglish
    Pages (from-to)320-325
    Number of pages6
    JournalAnaesthesia and Intensive Care
    Volume45
    Issue number3
    Publication statusPublished - 1 May 2017

    Fingerprint

    General Anesthesia
    Safety
    Iron
    Ferritins
    Hemodynamics
    Incidence
    Hypotension
    teferrol
    Anemia
    Hypersensitivity
    Hemoglobins
    Outpatients
    Anesthesia
    Maintenance
    Staining and Labeling
    Skin
    Population

    Cite this

    @article{8a80837fa8ec49b585234ac0bde04af6,
    title = "Efficacy and safety of ultra rapid iron polymaltose infusion during general anaesthesia",
    abstract = "To assess the efficacy and safety of ultra rapid (15 minute) infusion of iron polymaltose to iron deficient patients during general anaesthesia, we performed a prospective, interventional non-randomised study on 99 adult patients with iron deficiency with or without anaemia presenting for surgery under general anaesthesia. Over 15 minutes during the maintenance phase of anaesthesia, patients were given iron polymaltose, 500 mg if not anaemic, or 1,000 mg if anaemic. Haemodynamic stability, immediate or delayed iron-related side-effects and efficacy at six weeks were assessed. The incidence of significant hypotension or the requirement for vasopressor was not different before, during or after the iron infusion. There were no serious intraoperative events (allergic reactions or skin staining). Mean (standard deviation, SD) haemoglobin rose from 121 (14) g/l preoperatively to 131 (12) g/l at six weeks (P <0.001). Mean (SD) ferritin rose from 17 (12) μg/l to 110 (83) μg/l by six weeks (P <0.001). At six weeks only four out of 64 contactable patients (6.25{\%}) had a ferritin of <30 μg/l. The incidence of immediate or delayed side-effects was similar to patients undergoing outpatient iron polymaltose infusions and reflective of a post-surgical population. We conclude that up to 1,000 mg of iron polymaltose can be given over 15 minutes without significant haemodynamic compromise to selected patients undergoing general anaesthesia. Iron polymaltose administered in this way appears efficacious in treating iron deficiency.",
    keywords = "Anaemia, Anaesthesia, General, Iron, Iron deficiency",
    author = "Browning, {R. M.} and N. Alakeson and O'Loughlin, {E. J.}",
    year = "2017",
    month = "5",
    day = "1",
    language = "English",
    volume = "45",
    pages = "320--325",
    journal = "Anaesthesia Intensive Care",
    issn = "0310-057X",
    publisher = "Australian Society of Anaesthetists",
    number = "3",

    }

    Efficacy and safety of ultra rapid iron polymaltose infusion during general anaesthesia. / Browning, R. M.; Alakeson, N.; O'Loughlin, E. J.

    In: Anaesthesia and Intensive Care, Vol. 45, No. 3, 01.05.2017, p. 320-325.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Efficacy and safety of ultra rapid iron polymaltose infusion during general anaesthesia

    AU - Browning, R. M.

    AU - Alakeson, N.

    AU - O'Loughlin, E. J.

    PY - 2017/5/1

    Y1 - 2017/5/1

    N2 - To assess the efficacy and safety of ultra rapid (15 minute) infusion of iron polymaltose to iron deficient patients during general anaesthesia, we performed a prospective, interventional non-randomised study on 99 adult patients with iron deficiency with or without anaemia presenting for surgery under general anaesthesia. Over 15 minutes during the maintenance phase of anaesthesia, patients were given iron polymaltose, 500 mg if not anaemic, or 1,000 mg if anaemic. Haemodynamic stability, immediate or delayed iron-related side-effects and efficacy at six weeks were assessed. The incidence of significant hypotension or the requirement for vasopressor was not different before, during or after the iron infusion. There were no serious intraoperative events (allergic reactions or skin staining). Mean (standard deviation, SD) haemoglobin rose from 121 (14) g/l preoperatively to 131 (12) g/l at six weeks (P <0.001). Mean (SD) ferritin rose from 17 (12) μg/l to 110 (83) μg/l by six weeks (P <0.001). At six weeks only four out of 64 contactable patients (6.25%) had a ferritin of <30 μg/l. The incidence of immediate or delayed side-effects was similar to patients undergoing outpatient iron polymaltose infusions and reflective of a post-surgical population. We conclude that up to 1,000 mg of iron polymaltose can be given over 15 minutes without significant haemodynamic compromise to selected patients undergoing general anaesthesia. Iron polymaltose administered in this way appears efficacious in treating iron deficiency.

    AB - To assess the efficacy and safety of ultra rapid (15 minute) infusion of iron polymaltose to iron deficient patients during general anaesthesia, we performed a prospective, interventional non-randomised study on 99 adult patients with iron deficiency with or without anaemia presenting for surgery under general anaesthesia. Over 15 minutes during the maintenance phase of anaesthesia, patients were given iron polymaltose, 500 mg if not anaemic, or 1,000 mg if anaemic. Haemodynamic stability, immediate or delayed iron-related side-effects and efficacy at six weeks were assessed. The incidence of significant hypotension or the requirement for vasopressor was not different before, during or after the iron infusion. There were no serious intraoperative events (allergic reactions or skin staining). Mean (standard deviation, SD) haemoglobin rose from 121 (14) g/l preoperatively to 131 (12) g/l at six weeks (P <0.001). Mean (SD) ferritin rose from 17 (12) μg/l to 110 (83) μg/l by six weeks (P <0.001). At six weeks only four out of 64 contactable patients (6.25%) had a ferritin of <30 μg/l. The incidence of immediate or delayed side-effects was similar to patients undergoing outpatient iron polymaltose infusions and reflective of a post-surgical population. We conclude that up to 1,000 mg of iron polymaltose can be given over 15 minutes without significant haemodynamic compromise to selected patients undergoing general anaesthesia. Iron polymaltose administered in this way appears efficacious in treating iron deficiency.

    KW - Anaemia

    KW - Anaesthesia

    KW - General

    KW - Iron

    KW - Iron deficiency

    UR - http://www.scopus.com/inward/record.url?scp=85019443884&partnerID=8YFLogxK

    M3 - Article

    VL - 45

    SP - 320

    EP - 325

    JO - Anaesthesia Intensive Care

    JF - Anaesthesia Intensive Care

    SN - 0310-057X

    IS - 3

    ER -